MarketScreener Editorial Features argenx SE
Stocks
ARGX
NL0010832176
Biotechnology & Medical Research
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 751.20 EUR | -0.11% |
|
-1.05% | +4.85% |
| 07-10 | European Equities Traded in the US as American Depositary Receipts Decline Friday | MT |
| 07-07 | RBC Capital Adjusts argenx SE ADR Price Target to $945 From $890, Maintains Outperform Rating | MT |
MarketScreener Editorial Features
Search
No results match your criteria
- Stock Market
- Stocks
- ARGX Stock
- News argenx SE
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition




















